These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 18634778

  • 1. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
    Martinez ML, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):224-30. PubMed ID: 18634778
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.
    Castro MM, Rizzi E, Figueiredo-Lopes L, Fernandes K, Bendhack LM, Pitol DL, Gerlach RF, Tanus-Santos JE.
    Atherosclerosis; 2008 Jun 04; 198(2):320-31. PubMed ID: 18054360
    [Abstract] [Full Text] [Related]

  • 5. Oxidative stress contributes to renovascular hypertension.
    Oliveira-Sales EB, Dugaich AP, Carillo BA, Abreu NP, Boim MA, Martins PJ, D'Almeida V, Dolnikoff MS, Bergamaschi CT, Campos RR.
    Am J Hypertens; 2008 Jan 04; 21(1):98-104. PubMed ID: 18091751
    [Abstract] [Full Text] [Related]

  • 6. Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.
    Marçal DM, Rizzi E, Martins-Oliveira A, Ceron CS, Guimaraes DA, Gerlach RF, Tanus-Santos JE.
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan 04; 383(1):35-44. PubMed ID: 21058008
    [Abstract] [Full Text] [Related]

  • 7. Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling.
    Castro MM, Rizzi E, Prado CM, Rossi MA, Tanus-Santos JE, Gerlach RF.
    Matrix Biol; 2010 Apr 04; 29(3):194-201. PubMed ID: 19969080
    [Abstract] [Full Text] [Related]

  • 8. Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension.
    Ceron CS, Rizzi E, Guimaraes DA, Martins-Oliveira A, Cau SB, Ramos J, Gerlach RF, Tanus-Santos JE.
    Matrix Biol; 2012 May 04; 31(4):261-70. PubMed ID: 22342460
    [Abstract] [Full Text] [Related]

  • 9. Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability.
    Castro MM, Rizzi E, Ceron CS, Guimaraes DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE.
    Nitric Oxide; 2012 Mar 31; 26(3):162-8. PubMed ID: 22327038
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
    Eagleton MJ, Peterson DA, Sullivan VV, Roelofs KJ, Ford JA, Stanley JC, Upchurch GR.
    J Surg Res; 2002 May 01; 104(1):15-21. PubMed ID: 11971672
    [Abstract] [Full Text] [Related]

  • 11. Euterpe oleracea Mart.-derived polyphenols prevent endothelial dysfunction and vascular structural changes in renovascular hypertensive rats: role of oxidative stress.
    da Costa CA, de Oliveira PR, de Bem GF, de Cavalho LC, Ognibene DT, da Silva AF, Dos Santos Valença S, Pires KM, da Cunha Sousa PJ, de Moura RS, Resende AC.
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Dec 01; 385(12):1199-209. PubMed ID: 23052352
    [Abstract] [Full Text] [Related]

  • 12. β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E, Guimaraes DA, Ceron CS, Prado CM, Pinheiro LC, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE.
    Free Radic Biol Med; 2014 Aug 01; 73():308-17. PubMed ID: 24933619
    [Abstract] [Full Text] [Related]

  • 13. Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension.
    Guimaraes DA, Rizzi E, Ceron CS, Oliveira AM, Oliveira DM, Castro MM, Tirapelli CR, Gerlach RF, Tanus-Santos JE.
    Basic Clin Pharmacol Toxicol; 2011 May 01; 108(5):318-25. PubMed ID: 21176109
    [Abstract] [Full Text] [Related]

  • 14. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E, Ceron CS, Guimaraes DA, Prado CM, Rossi MA, Gerlach RF, Tanus-Santos JE.
    Exp Mol Pathol; 2013 Feb 01; 94(1):1-9. PubMed ID: 23073243
    [Abstract] [Full Text] [Related]

  • 15. Ca2+-activated K+ channels underlying the impaired acetylcholine-induced vasodilation in 2K-1C hypertensive rats.
    Callera GE, Yogi A, Tostes RC, Rossoni LV, Bendhack LM.
    J Pharmacol Exp Ther; 2004 Jun 01; 309(3):1036-42. PubMed ID: 14978190
    [Abstract] [Full Text] [Related]

  • 16. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J, Markovic S, Wehland M, Melenhorst WB, van Goor H, Kreutz R.
    J Pharmacol Exp Ther; 2006 Jan 01; 316(1):8-16. PubMed ID: 16166267
    [Abstract] [Full Text] [Related]

  • 17. Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension.
    Blascke de Mello MM, Parente JM, Schulz R, Castro MM.
    Vascul Pharmacol; 2019 May 01; 116():36-44. PubMed ID: 30339939
    [Abstract] [Full Text] [Related]

  • 18. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.
    Ceron CS, Castro MM, Rizzi E, Montenegro MF, Fontana V, Salgado MC, Gerlach RF, Tanus-Santos JE.
    Br J Pharmacol; 2010 May 01; 160(1):77-87. PubMed ID: 20331602
    [Abstract] [Full Text] [Related]

  • 19. Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreases vascular remodeling in renovascular hypertension.
    Ceron CS, Rizzi E, Guimarães DA, Martins-Oliveira A, Gerlach RF, Tanus-Santos JE.
    Free Radic Biol Med; 2013 Dec 01; 65():47-56. PubMed ID: 23806385
    [Abstract] [Full Text] [Related]

  • 20. Effects of renovascular hypertension on reproductive function in male rats.
    Breigeiron MK, Lucion AB, Sanvitto GL.
    Life Sci; 2007 Apr 03; 80(17):1627-34. PubMed ID: 17316702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.